Astellas Pharma GmbH

Aradigm Announces Third Quarter 2009 Financial Results.(Financial report)
Biotech Week; 11/18/2009; 1285 words; ...and its European partner, Desitin Pharmaceuticals, GmbH ("Desitin"), announced that Desitin has filed for...commercialization in the U.S. by Zogenix and its partner, Astellas Pharma US, Inc. We are continuing in our efforts to seek new...

BIO-Europe 2009 Announces Program Highlights.
Pediatrics Week; 11/7/2009; 2473 words; ...Biopharma, Simon Dew of Astellas Pharma Europe, Brad Prosek of...Oskar Gold of Vetter Pharma International, Gregor...include Gayle Mills of ROXRO Pharma, Robert Wills of Johnson...Wolf of Bio Innovations GmbH and Ludovic Lacaine of...

Green Zone Watch at GreenArrowStock.com: Aradigm Corporation (ARDM).
M2 Presswire; 11/5/2009; 1726 words; ...and its European partner, Desitin Pharmaceuticals, GmbH ("Desitin"), announced that Desitin has filed for...commercialization in the U.S. by Zogenix and its partner, Astellas Pharma US, Inc. We are continuing in our efforts to seek new...

Positive 'Restless Legs' Data Send XenoPort Shares Soaring.
BIOWORLD Today; 11/3/2009; 1391 words; ...due from Japanese partner, Tokyo-based Astellas Pharma Inc. That deal, signed in late 2005, gives Astellas rights to develop and commercialize XP13512...and Mirapexin (Boehringer Ingelheim GmbH), are designed to act on the dopamine...

MerLion Buys Combinature, Athelas In Three-Way Merger.
BIOWORLD Today; 11/3/2009; 1043 words; ...based Aurelia Private Equity GmbH; Brandenburg Capital GmbH, of Potsdam, Germany; Singapore...have been spun out of large pharma companies. "It would have...of Abbott Park, Ill.; and Astellas Pharma Inc., of Tokyo. That list...